Barclays Maintains Equal-Weight on Astrana Health, Raises Price Target to $37
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Barclays analyst Andrew Mok maintains Astrana Health (NASDAQ:ASTH) with a Equal-Weight and raises the price target from $26 to $37.
Barclays analyst Andrew Mok maintains Astrana Health (NASDAQ:ASTH) with a Equal-Weight and raises the price target from $26 to $37.
